Armata Pharmaceuticals Management
Management criteria checks 1/4
Armata Pharmaceuticals' CEO is Deborah Birx, appointed in Jul 2023, has a tenure of less than a year. directly owns 0.72% of the company’s shares, worth €602.83K. The average tenure of the management team and the board of directors is 0.8 years and 4.3 years respectively.
Key information
Deborah Birx
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | 0.7% |
Management average tenure | less than a year |
Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO
Deborah Birx (66 yo)
less than a year
Tenure
Dr. Deborah L. Birx, M.D., serves as CEO & Director of Armata Pharmaceuticals, Inc. since July 11, 2023. He is Member of Palantir Federal Advisory Board at Palantir Technologies Inc. since October 2022. Sh...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chief Medical Officer | 3.6yrs | US$839.24k | 0.12% $ 100.4k | |
CEO & Director | less than a year | no data | 0.72% $ 602.8k | |
VP, Corporate Controller & Principal Financial Officer | less than a year | no data | 0.028% $ 23.2k | |
Vice President of Operations | less than a year | no data | no data | |
Senior Vice President of Business & Corporate Development | less than a year | no data | no data |
0.8yrs
Average Tenure
66yo
Average Age
Experienced Management: TG1N's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CEO & Director | less than a year | no data | 0.72% $ 602.8k | |
Independent Director | 5yrs | US$177.11k | 0% $ 0 | |
Independent Director | 3.1yrs | US$199.11k | 0% $ 0 | |
Independent Director | 4.3yrs | US$165.11k | 0% $ 0 | |
Member of C16G2 Clinical Advisory Board | no data | no data | no data | |
Independent Director | 4.3yrs | US$167.11k | 0% $ 0 | |
Independent Director | 4.6yrs | US$169.11k | 0% $ 0 | |
Independent Chairman of the Board | 3.4yrs | US$178.11k | 0% $ 0 | |
Member of C16G2 Clinical Advisory Board | no data | no data | no data | |
Member of C16G2 Clinical Advisory Board | no data | no data | no data | |
Member of C16G2 Clinical Advisory Board | no data | no data | no data | |
Member of C16G2 Clinical Advisory Board | no data | no data | no data |
4.3yrs
Average Tenure
63yo
Average Age
Experienced Board: TG1N's board of directors are considered experienced (4.3 years average tenure).